These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1371882)

  • 1. Role of the KIT protooncogene in normal and malignant human hematopoiesis.
    Ratajczak MZ; Luger SM; DeRiel K; Abrahm J; Calabretta B; Gewirtz AM
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1710-4. PubMed ID: 1371882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional analysis of protooncogene Vav's role in adult human hematopoiesis.
    Luger SM; Ratajczak J; Ratajczak MZ; Kuczynski WI; DiPaola RS; Ngo W; Clevenger CV; Gewirtz AM
    Blood; 1996 Feb; 87(4):1326-34. PubMed ID: 8608221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis.
    Caracciolo D; Venturelli D; Valtieri M; Peschle C; Gewirtz AM; Calabretta B
    J Clin Invest; 1990 Jan; 85(1):55-61. PubMed ID: 2404028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-kit expression by CD34+ bone marrow progenitors and inhibition of response to recombinant human interleukin-3 following exposure to c-kit antisense oligonucleotides.
    Catlett JP; Leftwich JA; Westin EH; Grant S; Huff TF
    Blood; 1991 Dec; 78(12):3186-91. PubMed ID: 1720696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7.
    Orlic D; Anderson S; Biesecker LG; Sorrentino BP; Bodine DM
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4601-5. PubMed ID: 7538677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
    Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
    Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis.
    Methia N; Louache F; Vainchenker W; Wendling F
    Blood; 1993 Sep; 82(5):1395-401. PubMed ID: 7689867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro.
    Gewirtz AM; Calabretta B
    Science; 1988 Dec; 242(4883):1303-6. PubMed ID: 2461588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage-specific requirement of c-abl function in normal hematopoiesis.
    Caracciolo D; Valtieri M; Venturelli D; Peschle C; Gewirtz AM; Calabretta B
    Science; 1989 Sep; 245(4922):1107-10. PubMed ID: 2672339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells.
    Ikeda H; Kanakura Y; Tamaki T; Kuriu A; Kitayama H; Ishikawa J; Kanayama Y; Yonezawa T; Tarui S; Griffin JD
    Blood; 1991 Dec; 78(11):2962-8. PubMed ID: 1720040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
    Bühring HJ; Ullrich A; Schaudt K; Müller CA; Busch FW
    Leukemia; 1991 Oct; 5(10):854-60. PubMed ID: 1720490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The c-kit proto-oncogene in normal and malignant human hematopoiesis.
    Ratajczak MZ; Luger SM; Gewirtz AM
    Int J Cell Cloning; 1992 Jul; 10(4):205-14. PubMed ID: 1379619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
    Hassan HT; Zander A
    Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
    Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression.
    Jacobsen FW; Dubois CM; Rusten LS; Veiby OP; Jacobsen SE
    J Immunol; 1995 Apr; 154(8):3732-41. PubMed ID: 7535812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes.
    Siitonen T; Savolainen ER; Koistinen P
    Leukemia; 1994 Apr; 8(4):631-7. PubMed ID: 7512174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.
    Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ
    Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers.
    Rosti V; Bergamaschi G; Ponchio L; Cazzola M
    Leukemia; 1992 Jan; 6(1):1-7. PubMed ID: 1736009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.